LCAT and metabolic syndrome: Here, we described a reduction in LCAT activity in patients with central obesity and MetS that leads to functional PL/cholesterol remodelling, and we investigated the association of multiple lipidomic ratios with standard enzymatic activity assays as valuable predictors of LCAT activity (as confirmed by a strong correlation among direct/indirect measurements).